aTyr Pharma, Inc. (ATYR) vs Quince Therapeutics, Inc. (QNCX)

aTyr Pharma, Inc. and Quince Therapeutics, Inc. are both Biotechnology companies. aTyr Pharma, Inc. and Quince Therapeutics, Inc. are of similar size ($31.4M and $30.5M). Across the 9 metrics below, Quince Therapeutics, Inc. leads on 5 and aTyr Pharma, Inc. on 4.

Valuation

Metric ATYR QNCX Biotechnology median
P/E n/m n/m 7.88
P/S 2.64 n/m 11.47
P/B 0.61 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.42 n/m 0.74
EV/Sales (2.39) n/m 10.73
Earnings yield (206.67%) (459.06%) (28.84%)
Free cash flow yield (186.29%) (24.87%) (23.03%)

Profitability

Metric ATYR QNCX Biotechnology median
Gross margin 1.72% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (98.67%) 784.09% (57.72%)
Return on assets (70.97%) (76.68%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATYR QNCX Biotechnology median
Revenue growth (TTM) 6.78% — 5.64%
EPS growth (last fiscal year) 6.98% (28.24%) —
Revenue growth, 5-year CAGR (14.75%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATYR QNCX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.12 14.52 4.73
Net debt to EBITDA 1.01 0.00 0.96

Dividend

Metric ATYR QNCX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ATYR QNCX Biotechnology median
Market cap 31.38m 30.51m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack